XML 300 R52.htm IDEA: XBRL DOCUMENT v3.26.1
Performance B.4.1. Share-based compensation - Plan awards and shares expected to vest (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
shares
Dec. 31, 2023
shares
Dec. 31, 2022
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Shares issued (in shares) (434,675) (270,850)    
Shares still expected to vest (in shares) 502,914 474,225    
2025 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 222,817      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) 0      
Shares cancelled in 2024 (in shares) 0      
Total before issuances (in shares) 222,817      
Shares issued (in shares) (70,252)
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 152,565      
Estimated cost over the vesting period | $ $ 7      
2024 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 695,936      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (43,852)      
Shares cancelled in 2024 (in shares) (438,396)      
Total before issuances (in shares) 213,688      
Shares issued (in shares) (43,612)
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 170,076      
Estimated cost over the vesting period | $ $ 7      
2024 Performance Plan | Share Appreciation Rights Units (SARs)        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Shares still expected to vest (in shares) 123,103      
2024 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 1,139,838      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (55,244)      
Shares cancelled in 2024 (in shares) (229,963)      
Total before issuances (in shares) 854,631      
Shares issued (in shares) (349,551) (135,092)
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 369,988      
Estimated cost over the vesting period | $ $ 22      
2023 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 818,842      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (233,983)      
Shares cancelled in 2024 (in shares) (308,172)      
Total before issuances (in shares) 276,687      
Shares issued (in shares) (105,193) (66,519) (31,124)
Performance conditions not met (in shares) 75,248      
Shares still expected to vest (in shares) 149,099      
Estimated cost over the vesting period | $ $ 17      
2023 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 2,375,143      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (156,243)      
Shares cancelled in 2024 (in shares) (244,537)      
Total before issuances (in shares) 1,974,363      
Shares issued (in shares) (445,526) (824,237) (354,331)
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 350,269      
Estimated cost over the vesting period | $ $ 43      
2022 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 306,641      
Number of shares for rights offering, in share-based payment arrangement (in shares) 83,926      
Revision for forfeitures (in shares) (72,290)      
Shares cancelled in 2024 (in shares) (144,108)      
Total before issuances (in shares) 174,169      
Shares issued (in shares) (136,547) (49,245) (29,885)
Performance conditions not met (in shares) 41,508      
Shares still expected to vest (in shares) 0      
Estimated cost over the vesting period | $ $ 0      
2022 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 913,450      
Number of shares for rights offering, in share-based payment arrangement (in shares) 227,947      
Revision for forfeitures (in shares) (84,684)      
Shares cancelled in 2024 (in shares) (33,305)      
Total before issuances (in shares) 1,023,408      
Shares issued (in shares) (220,470) (312,725) (476,256) (13,957)
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 0      
Estimated cost over the vesting period | $ $ 0